Graham Capital Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-71,349
| Closed | -$633K | – | 1460 |
|
|
2025
Q1 | $633K | Buy |
+71,349
| New | +$633K | 0.01% | 684 |
|
|
2024
Q4 | – | Sell |
-43,203
| Closed | -$1.18M | – | 1366 |
|
|
2024
Q3 | $1.18M | Buy |
43,203
+26,850
| +164% | +$735K | 0.02% | 384 |
|
|
2024
Q2 | $400K | Buy |
+16,353
| New | +$400K | 0.01% | 630 |
|
|
2023
Q3 | – | Sell |
-8,815
| Closed | -$204K | – | 1186 |
|
|
2023
Q2 | $204K | Buy |
+8,815
| New | +$204K | 0.01% | 800 |
|